Brg-or hBrm-associated factor (BAF) complexes, a chromatin-remodeling complex family of mammalian cells, facilitate transcriptional activity by remodeling nucleosome structure. Brg1 is the core subunit of Brg-associated factor complexes. In the present study, we investigated the spatial relationship between Brg1 and nuclear factor 1 (NF1/CTF) and RNA polymerase II (RNAP II) upon gene transcriptional activation in vivo by employing immuno-gold labeling. The data showed that Brg1 was closely co-localized with NF1/CTF and RNAP II in HeLa cells. Moreover, the co-immunoprecipitation assay further revealed that Brg1 can be isolated together with NF1/CTF and RNAP II in the ConA-stimulated, but not the resting, T lymphocyte. The combined results suggested that BAF complexes can interact with NF1/CTF and RNAP II, and this interaction is closely dependent on the activation of gene transcription.
The chromatin structure in eukaryotic cells is crucial for gene transcription. The basic structural unit of chromatin is the nucleosome, in which the octameric histones are wrapped by DNA. Previous accumulated data have shown that DNA's tight binding of histones restrains gene transcription, and chromatin needs to be modulated to facilitate the transcriptional activation [1] . SWI/SNF complexes have been shown to play a role in the remodeling of chromatin. Brg-or hBrm-associated factor (BAF) complexes, which are homologous to SWI/SNF complexes in mammalian cells, display ATPase activities and contribute to gene transcription by sliding between DNA and histones [2] .
The eukaryotic gene transcription is mainly mediated by RNA polymerase II (RNAP II), which functions as a form of holoenzyme that includes RNAP II, general transcription factors and the suppressor of RNA polymerase B (SRB)/mediator complex [3] . It has been reported that BAF complexes exist in the extract of the RNAP II holoenzyme, so that a possible model for the function of the BAF complex in gene transcription can be inferred: the BAF complex contributes to the modulation of transcription through its interaction with transcriptional factors and RNAP II [4] . The nuclear factor 1 (NF1) family of site-specific DNA-binding proteins (also known as CTF or CAAT box transcription factors) are a type of transcriptional factor that functions both in viral DNA replication and in the regulation of gene transcription [5] . In general, a pre-initiation complex is required for gene transcription. Whether the BAF complex, together with NF1/CTF and RNAP II, participates in the forming of the pre-initiation complex is still being debated.
In the present work, we studied the spatial relationship and the interaction between Brg1 and NF1/CTF and RNAP II in transcriptionally activated cells by dual-immunogold labeling and immunoprecipitation assay. The results showed that Brg1 was obviously co-localized and interacted with NF1/CTF and RNAP II in the nucleus.
Based on this, we concluded that the BAF complex and NF1/CTF are closely associated with RNAP II, and these components take part in the formation of the preinitiation complex and trigger the RNAP II-mediated gene transcription.
Materials and Methods

Antibodies
The monoclonal antibody (mouse IgG) against Brg1 was supplied by Dr. Keji ZHAO. The polyclonal antibody (rabbit IgG) against the core subunit of RNAP II and the polyclonal antibody (rabbit IgG) against NF1/CTF, which recognizes the conserved N-terminal amino acid sequence, were purchased from Santa Cruz Corporation (Santa Cruz, CA, USA). The sheep anti-mouse IgG conjugated with 5 nm colloidal gold and the sheep anti-rabbit IgG conjugated with 17 nm colloidal gold were purchased from the Beijing Academy of Military Medicine (Beijing, China). The polyclonal antibody AC 21 (rabbit IgG against Bcl-2) was purchased from Santa Cruz Corporation. The monoclonal anti-β-actin antibody AC-15 was purchased from Sigma (St. Louis, MO, USA).
Cells
HeLa cells and Jurkat cells were cultured in RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal calf serum. Mouse spleen T lymphocytes were isolated as previously described [6] . Briefly, tissue culture dishes were allowed to incubate with affinitypurified goat anti-mouse antibodies (50 µg/ml) at room temperature. After 2 h, the dishes were washed 3 times with PBS, and spleen cells were added at a concentration of 2×10 7 cells/ml in RPMI 1640 medium. After 30 min, the cultures were gently swirled to collect the non-adherent cells, and the purified T lymphocytes were obtained by repeating this procedure. The T lymphocytes were incubated with concanavalin A (ConA, 10 µg/ml) at 37 °C for activation. The treated and untreated cells were cultured in a humidified atmosphere of 5% CO 2 .
Dual-immunogold labeling
HeLa cells were collected and fixed in 2.5% glutaraldehyde (in 0.1 M phosphate buffer, pH 7.4) for 2 h. The fixed pellets were dehydrated in ethanol and embedded in Lowicryl K 4 M (Chemische Werke Lowi GmbH & Company, Waldkraiburg, Germany) at -40 °C. Ultrathin sections (60-80 nm) were prepared with a Reichert-Jung microtome (Markham, Ontario, Canada), and collected on Formvar-coated gold grids. Before labeling, the sections were treated with 1% saturated NaIO 4 for 20 min, washed by deionized water and 10 mM PBSTG (pH 7.4, containing 0.9% NaCl, 0.2% Tween-20 and 15 mM glycine), then blocked with 1% BSA in 10 mM PBSTG (pH 7.4) for 20 min. For dual labeling of Brg1 and RNAP II, the sections were subsequently incubated with the monoclonal anti-Brg1 antibody (mouse IgG) at 1:40 dilution in 10 mM PBSTG (pH 7.4) containing 0.1% BSA at 4 °C overnight. Then, the sections were washed in 0.01 M PBSTG (pH 7.4 and pH 8.0) and incubated with the sheep anti-mouse IgG conjugated with 5 nm colloidal gold at 1:20 dilution in 10 mM PBSTG (pH 8.0, containing 0.1% BSA) at room temperature for 2 h. After washing with 10 mM PBS and deionized water, the second labeling process was conducted by repeating the above process, except that the monoclonal anti-Brg1 antibody was replaced by the polyclonal anti-RNAP II antibody (rabbit IgG) and the 5 nm colloidal gold-conjugated sheep anti-mouse IgG was replaced by the anti-rabbit IgG antibody conjugated with 17 nm colloidal gold [7, 8] . For dual labeling of Brg1 and NF1/CTF, the labeling process was the same as the labeling of Brg1 and RNAP II, except that the polyclonal anti-NF1/CTF antibody (rabbit IgG) was used for the second labeling process. All the sections were washed in distilled water, air dried, examined and photographed with a Hitachi 600-B transmission electron microscope.
Preparation of T lymphocyte nuclei and immunoblotting
The procedure was adapted from Wang et al. [9] . A total of 10 6 cells were resuspended in 200 µl of isolation buffer [3.75 mM Tris-HCl (pH 7.5), 0.05 mM spermine, 0.125 mM spermidine, 0.5 mM MgCl 2 , 20 mM KCl, 0.25 mM EDTA (pH 8.0), 0.125 mM EGTA (pH 8.0), 1 mM DTT, 0.5 mM PMSF, 5 µg/ml pepstatin, 5 µg/ml leupeptin and 5 µg/ml aprotinin, 0.5% NP-40] at 4 °C for 20 min. Nuclei were pelleted by centrifugation at 1000 g for 10 min. The nuclear extracts were prepared by dissolving the isolated nuclei in Laemmli's sample buffer at 100 °C for 5 min. A 4%-20% gradient polyacrylamide gel electrophoresis in the presence of SDS was performed. Electrophoretic transfer of proteins from the gel to the nitrocellulose filter was carried out at 200 V for 2 h by using a Trans-blot cell (Bio-Rad, Hercules, CA, USA) in the buffer containing 25 mM Tris-HCl, 129 mM glycine and 20% methanol and maintained at a temperature below 15 °C. After the transfer, the filter was blocked in PBST buffer containing 3% defatted dry milk at room tempera-ture for 1 h. Then the filter was washed with PBST buffer, incubated in the presence of 3% defatted dry milk and labeled with the appropriate amount of antibody at 37 °C for 1 h. After washing, the filter was incubated with the indicated secondary antibody in the presence of 3% defatted dry milk PBST buffer for another 30 min. Finally, the filter was washed and visualized by using 3-amino-9-ethylcarbazole (AEC) as a substrate.
Immunoprecipitation
Cells cultured in RPMI medium were cross-linked with 1% formaldehyde at 37 °C for 20 min and washed twice. Approximately 10 8 nuclei free of cytoplasmic contaminants were extracted in lysis buffer (containing 0.5 mg/ml deoxyribonuclease, 0.2 mg/ml ribonuclease, 1 mM PMSF and 10 µg/ml aprotinin) and centrifuged at 10,000 g for 10 min, and 900 µl of the supernatant mixed with 100 µl of 4×immunoprecipitation buffer [1% Triton-100, 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 1 mM EGTA (pH 8.0), 0.2 mM PMSF, 0.5% NP-40] were incubated with 5 µg of the indicated antibody at 4 °C for 1 h. Then 10 µl of 50% protein A-Sepharose 4B was added and incubated at 4 °C for 30 min to precipitate the immunocomplexes. The immunoprecipitates were washed with 1×immunoprecipitation buffer and analyzed by immunoblotting with the indicated antibody, using AEC as a substrate [9] . The antibodies were diluted at 1:100 for immunoprecipitating proteins in the extracts and at 1:1000 for identification of the precipitated protein.
Results
The expression of Brg1 and NF1/CTF is related to the activation of cells
To study the relationship between the BAF complex and NF1/CTF in the activated cells, we first detected the expression of Brg1 and NF1/CTF in the nuclear extract of the HeLa and Jurkat cells. The result showed that there was abundant expression of Brg1 and NF1/CTF in the HeLa and Jurkat cells [ Fig. 1(A) ]. To confirm that the expression of Brg1 and NF1/CTF in the nuclei was associated with the transcriptional activation of cells, we further analyzed the expression of Brg1 and NF1/CTF by using the T lymphocyte activating system. T lymphocytes isolated from the mouse spleen were treated with ConA and collected at time intervals. The nuclei from each group of T lymphocytes were collected, and the nuclear extracts were subjected to ELISA analysis. The results showed that the expression of Brg1 and NF1/CTF increased gradually after ConA stimulation and dropped after 24 h (data not shown). We compared the quantities of Brg1 and NF1/CTF in the T lymphocytes stimulated by ConA for 15 h with those of resting T lymphocytes. Following the quantification of the protein concentration of each nuclear extract, the same amount of whole protein was tested by electrophoresis. Western blotting analysis further showed that no Brg1 and NF1/CTF was detected in the untreated mouse spleen T lymphocyte and the expression of Brg1 and NF1/CTF was obvious in the cells treated for 15 h [ Fig. 1(B) ], suggesting that the expression of Brg1 and the transcription factor NF1/CTF is closely related to the activation of cells.
Dual-immunogold labeling of Brg1 with NF1/CTF and RNAP II
Since the expression of Brg1 and NF1/CTF is related to transcriptional activation and most of the eukaryotic genes are transcribed by RNAP II, we explored the colocalization of Brg1 with NF1/CTF and RNAP II by using the technique of dual-immunogold labeling. As described in "Materials and Methods", the primary antibodies against Brg1 and RNAP II were used first, and the visualization of two proteins was carried out using 5 nm colloidal gold for Brg1 and 17 nm colloidal gold for RNAP II. The results showed that the 5 nm gold particles for Brg1 and the 17 nm gold particles for RNAP II were specifically distributed in nuclei [ Fig. 2(A) ]. We chose 10 photographs and counted the randomly distributed gold particles. The distances between gold particle pairs were measured and sorted into three groups: 0-30 nm, 30-100 nm and 100-200 nm. The number of gold particles in each group was the average of 10 samples. The results showed that the distributive density of the 5 nm gold particles was 27.14 particles/µm 2 , and that of the 17 nm gold particles was 3.43 particles/µm 2 . Then the spatial relationships of the two kinds of gold particles were analyzed. Within 1 µm 2 , there were 1.9 particle pairs at a distance of 0-30 nm, 1 particle pair at a distance of 30-100 nm and 1.7 particle pairs at a distance of 100-200 nm. According to previous studies, the transcriptional foci are 70-100 nm in diameter and two proteins are functionally related if the distance between them is within 100 nm [8] . Of all the measured particle pairs, more than 60% of the distances were within 100 nm, which meant that BAF complexes containing Brg1 might be closely related to RNAP II ( Table 1) . We also analyzed the relationship between Brg1 and NF1/CTF using the same method. The results showed that the 5 nm gold particles for Brg1 and the 17 nm gold particles for NF1/CTF were also specifically distributed in the nuclei:
The distributive density of 5 nm gold particles was 13.94 particles/µm 2 , and that of 17 nm gold particles was 4.25 particles/µm 2 [ Fig. 2(B) ]. The number of gold particle pairs within 1 µm 2 was 4.4 at a distance of 0-30 nm, 3.22 at a distance of 30-100 nm and 3.4 at a distance of 100-200 nm. Of all the measured particle pairs, more than 70% of the distances were within 100 nm, indicating that the BAF complexes containing Brg1 were highly related to NF1/CTF ( Table 2) . The above results taken together suggest that the BAF complex is closely related to NF1/CTF and RNAP II.
Interaction between Brg1 and NF1/CTF and RNAP II
The dual-immunogold labeling assay displayed the spatial relationship between Brg1 and NF1/CTF and RNAP II. To further explore the relationship between Brg1 and NF1/CTF and RNAP II in gene transcription, we analyzed the interaction between Brg1 and NF1/CTF and RNAP II by using immunoprecipitation assay. First, the anti-Brg1 antibody was used to precipitate the nuclear extract, and anti-NF1/CTF and anti-RNAP II antibodies were used to detect NF1/CTF and RNAP II in the precipitated proteins, respectively. The results showed that NF1/CTF and RNAP II can be detected in the immunoprecipitation complexes. The anti-RNAP II antibody positively identified two proteins representing RNAP IIo (220 kDa) and RNAP IIa (200 kDa). With the same method, we then precipitated the nuclear extract by using anti-RNAP II and NF1/CTF antibodies. The results of the Western blot showed that Brg1 and NF1/CTF were detected in the anti-RNAP II antibody-precipitated complexes, and Brg1 and RNAP II were detected in the NF1/CTF antibody-precipitated complexes [ Fig. 3(A) ].
To confirm the specific purpose of the immunoprecipitative antibody, we used an anti-Bcl-2 antibody as a negative control. Bcl-2 is broadly expressed at the outer nuclear membrane and the outer membrane of mitochondria in most tumor cells. The anti-Bcl-2 antibody was unable to isolate Brg1, NF1/CTF or RNAP II from the nuclear extract of the HeLa cells [ Fig. 3(B) ]. The above results suggest that BAF complexes containing Brg1 interact with NF1/CTF and RNAP II in HeLa cells. To investigate if the interactions between Brg1 and NF1/CTF and RNAP II are related to gene transcription, a T lymphocyte activating system was employed for the immunoprecipitation assay. The mouse spleen T lymphocytes were isolated and one group was treated with ConA for 15 h, while the other group was not. Then the nuclei from both groups of cells were prepared. The immunoprecipitation assay was conducted using anti-Brg1, anti-NF1/CTF and anti-RNAP II antibodies. The results of the Western blot revealed that NF1/CTF, RNAP II and Brg1 were not detected in the precipitated complexes of resting cells, but all three proteins were identified for the activated cells [ Fig. 3(C) ]. To ensure that the absence of NF1/CTF, RNAP II and Brg1 in the nuclear extract of resting T lymphocytes was not because of the poor quality of the extract, equal amounts of the nuclear proteins of both resting and activated T lymphocytes were subjected to SDS-PAGE and blotted by an anti-β-actin antibody, and an approximate amount of β-actin was detected [ Fig. 3(D) ]. The combined results imply that the interaction between the BAF complex containing Brg1 and NF1/CTF and RNAP II depends on the activation of transcription.
Discussion
The RNAP II holoenzyme of eukaryotic cells mainly consists of RNAP II, SRB proteins and the general transcription factors. RNAP II needs the help of co-factors to initiate gene transcription [3, [10] [11] [12] . It remains debatable whether the chromatin-remodeling complex acts as part of the RNAP II holoenzyme in order to participate in the modulation of gene transcription. Some of the previous studies have shown that Brg1, the core subunit of the BAF complex, can be co-purified with RNAP II in yeast and mammalian cells. Brg1 can also be deposited along with SRB protein, which might bind to the CTDterminal domain of RNAP II to mediate the association of the BAF complex with RNAP II [4, 5, 13] . Our dualimmunogold labeling assay showed that Brg1 and RNAP II are closely related in spontaneously proliferative HeLa cells. The immunoprecipitation assay further confirmed that Brg1 and RNAP II are combined in the activated mouse spleen T lymphocytes, indicating that the interaction between the BAF complex and RNAP II is based on the activation of cells.
NF1/CTF is an important transcription factor and can bind to CCAAT-box to participate in the regulation of gene transcription. It has been reported that the activity of NF1/CTF can be increased by the BAF complex [14] . Experiments involving nucleosome reconstruction have shown that NF1/CTF binds to CSF1 promoters with a lower activity in the absence of the BAF complex, but binds to CSF1 promoters with a higher activity in the presence of the BAF complex, implying that the BAF complex is one of the main factors affecting the activity of NF1/CTF [15, 16] . The present study shows that Brg1 and NF1/CTF are closely related in HeLa cells and interact with each other in the activated mouse T lymphocytes, suggesting that the interaction between the BAF complex and NF1/CTF also depends on the activation of transcription. Based on the known information and the present data, we deduce that the BAF complex and NF1/CTF might act as components of the RNAP II holoenzyme to participate in the formation of the transcriptional pre-initiation complex. A possible mechanism might be that the BAF complex alters the structure of the nucleosome and exposes the special DNA-binding sequences, and then NF1/CTF binds to the DNA template and recruits RNAP II and other transcriptional factors to initiate gene transcription. 
